{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T20:58:59Z","timestamp":1773867539579,"version":"3.50.1"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1097\/ico.0b013e318172fbb1","type":"journal-article","created":{"date-parts":[[2008,8,21]],"date-time":"2008-08-21T10:14:43Z","timestamp":1219313683000},"page":"884-888","source":"Crossref","is-referenced-by-count":30,"title":["Use of Systemic T-lymphocyte Signal Transduction Inhibitors in the Treatment of Atopic Keratoconjunctivitis"],"prefix":"10.1097","volume":"27","author":[{"given":"Fahd","family":"Anzaar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micheal Joseph","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pooja","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mansoor","family":"Arif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saadia","family":"Farooqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C Stephen","family":"Foster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-7-20210204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0896-1549(01)00007-4","article-title":"Atopic ocular disease.","volume":"15","author":"Strauss","year":"2002","journal-title":"Ophthalmol Clin North Am"},{"key":"R3-7-20210204","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1096\/fj.02-1070com","article-title":"T helper (Th) 2 predominance in atopic diseases is due to preferential apoptosis of circulating memory\/effector Th1 cells.","volume":"17","author":"Akdis","year":"2003","journal-title":"FASEB J"},{"key":"R4-7-20210204","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/02713680490516738","article-title":"Predominance of infiltrating IL-4-producing T cells in conjunctiva of patients with allergic conjunctival disease.","volume":"29","author":"Matsuura","year":"2004","journal-title":"Curr Eye Res"},{"key":"R5-7-20210204","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0161-6420(90)32477-6","article-title":"Atopic keratoconjunctivitis.","volume":"97","author":"Foster","year":"1990","journal-title":"Ophthalmology"},{"key":"R6-7-20210204","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0002-9394(02)01726-9","article-title":"Toxic eosinophil granule protein deposition in corneal ulcerations and scars associated with atopic keratoconjunctivitis.","volume":"134","author":"Messmer","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"R7-7-20210204","first-page":"392","article-title":"The immunomodulatory effect of topical cyclosporin A in atopic keratoconjunctivitis.","volume":"40","author":"Hingorani","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R8-7-20210204","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-2002-26727","article-title":"Topical Fk506 in inflammatory corneal and conjunctival diseases. A pilot study.","volume":"219","author":"Reinhard","year":"2002","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"R9-7-20210204","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0002-9394(02)01982-7","article-title":"Topical tacrolimus treatment of atopic eyelid disease.","volume":"135","author":"Rikkers","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"R10-7-20210204","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s004170050252","article-title":"Inhibitory effects of FK506 on the development of experimental allergic\/immune-mediated blepharoconjunctivitis in Lewis rats by systemic but not by topical administration.","volume":"237","author":"Iwamoto","year":"1999","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R12-7-20210204","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1007\/s00417-006-0285-7","article-title":"Th1- and Th2-type cytokines in chronic ocular allergy.","volume":"244","author":"Leonardi","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R13-7-20210204","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/02713680490516738","article-title":"Predominance of infiltrating IL-4-producing T cells in conjunctiva of patients with allergic conjunctival disease.","volume":"29","author":"Matsuura","year":"2004","journal-title":"Curr Eye Res"},{"issue":"Suppl 2","key":"R14-7-20210204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2133.2006.07343.x","article-title":"Update on the use of ciclosporin in immune-mediated dermatoses.","volume":"155","author":"Griffiths","year":"2006","journal-title":"Br J Dermatol"},{"key":"R15-7-20210204","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ophtha.2003.05.035","article-title":"A randomized trial of topical cyclosporin 0.05% in topical steroid-resistant atopic keratoconjunctivitis.","volume":"111","author":"Akpek","year":"2004","journal-title":"Ophthalmology"},{"key":"R16-7-20210204","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/S0161-6420(97)30144-4","article-title":"Systemic cyclosporine A in severe atopic keratoconjunctivitis.","volume":"104","author":"Hoang-Xuan","year":"1997","journal-title":"Ophthalmology"},{"key":"R17-7-20210204","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/01.ico.0000240091.11854.14","article-title":"Systemic tacrolimus in the treatment of severe atopic keratoconjunctivitis.","volume":"25","author":"Stumpf","year":"2006","journal-title":"Cornea"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00003226-200809000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T01:41:48Z","timestamp":1618278108000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003226-200809000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e318172fbb1","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}